Last updated: February 13, 2026
Overview of NDC 27241-0049
NDC 27241-0049 refers to a specific formulation of a pharmaceutical product, most likely a branded or generic medication marketed in the United States. Exact details such as drug name, class, and indication are necessary but are not provided here. Based on the NDC format, the first set (27241) indicates the manufacturer or labeler, while the subsequent segments specify product details, formulation, and packaging.
Market Landscape
- Market Size and Demand Drivers
The drug's market size depends on its therapeutic area. For example, if the medication targets chronic conditions such as diabetes, hypertension, or cancer, demand is sustained and potentially growing. The following factors influence market size:
- Prevalence rates: The number of eligible patients.
- Treatment guidelines: Adoption rates among physicians.
- Competitive landscape: Presence of alternative therapies or generics.
- Market Penetration Pathways
- Brand presence: Market share of the branded version.
- Generics entry: Price erosion occurs once generic or biosimilar versions enter.
- Reimbursement policies: Coverage and formulary placement impact accessibility.
- Regulatory Factors
- FDA approval status: If the drug is on or near patent expiration, market dynamics shift.
- Pricing regulations: CMS and private payer policies influence rebate and discount strategies.
Pricing Trends and Projections
- Historical Pricing (if available):
- The average wholesale price (AWP) or list price.
- Price changes over time, especially pre- and post-patent expiration.
- Current Pricing Landscape:
- Brand Name: Typically ranges from $X to $Y per unit depending on the drug.
- Generics: Usually 20-80% lower than branded counterparts, contingent on market competition.
- Forecasted Price Trajectory (Next 3-5 years):
| Year |
Estimated Average Price |
Comments |
| 2023 |
$X per unit |
Current market price; potential for slight discounts due to competition |
| 2024 |
$X - 10% |
Anticipated generic entry, leading to price erosion |
| 2025 |
$Y per unit |
Increased generic penetration; price stabilizes or declines further |
| 2026 |
$Y - 15% |
Market equilibrium with available generics |
The projections depend heavily on the timeline of patent expiry, market entry of generics or biosimilars, and potential formulary restrictions.
Competitive Position
- Small Molecule Drugs: Prices tend to fall rapidly post-generic entry.
- Biologics/Biosimilars: Experience slower price erosion, with reductions of approximately 15-30% over 5-7 years.
Key Drivers Impacting Pricing
- Patent exclusivity duration.
- Negotiation power of payers.
- Market demand elasticity.
- Manufacturer strategies—e.g., rebates and discounts.
Market Risks and Opportunities
- Risks: Patent challenges, regulatory delays, or market saturation.
- Opportunities: Expansion into new indications, formulations, or delivery methods, increasing usage.
Conclusion
Without specific drug name, precise market size and pricing cannot be fully detailed. However, general patterns suggest initial high prices with potential reductions following patent expiry or increased competition. Price declines of 20-50% are common within five years post-generic launch.
Key Takeaways
- Market size depends on disease prevalence and treatment adoption.
- Prices are initially high, then tend to decline with generic competition.
- Price erosion around 20-50% is typical within five years of patent expiration.
- Formulary and negotiated discounts significantly influence net prices.
FAQs
-
What is the likely timeline for price decline for this drug?
Usually, significant price reductions occur within three to five years after generics enter the market.
-
How does patent expiration affect the market?
Once patents lapse, generic manufacturers can produce lower-cost versions, reducing branded drug prices.
-
Are biosimilars impacting price trends for biologic drugs?
Yes. Biosimilars generally reduce biologic prices by 15-30% over several years but lag behind small molecules in market penetration.
-
What factors influence the drug’s market penetration?
Regulatory approvals, physician acceptance, payer coverage, and patient demand determine how quickly a drug captures market share.
-
What role do rebates and discounts play?
Payer negotiations, rebates, and discounts significantly lower the effective net price paid by insurers and pharmacy benefit managers.
References
[1] FDA Drug Database
[2] IQVIA Institute Reports
[3] Medicare and Medicaid Price Data Reports
[4] Industry Pricing Trends Analysis
[5] MarketWatch, Pharmaceutical Industry Reports
